USA Ke Keʻena Ulalani, Kanakā Lahui Nā'Ileʻawa, Nā Hana Hana'Aiwi Pākehā

Ulipristal Acetate Powder (26784-99-4)

Rating: SKU: 26784-99-4. Māhele:

ʻO AASraw me ka synthesis a me ka hiki ke hoʻomohala mai ka metala a hiki i ka ʻōnaʻi o ka kumuhana ʻo Ulipristal Acetate Powder (26784-99-4), ma lalo o ka hoʻoponopono CGMP a me ka ʻōnaehana kāʻei kūpono kūpono.

Product Description

Ulipristal Acetate Powder (26784-99-4) wikiō


Ulipristal Acetate Powder (26784-99-4) Ske kūkala:

Hoʻolālā kūlohelohe: Product Name: Ulipristal Acetate (Ulipristal Acetate waena)
Kānāwai No.: 26784-99-4/126690-41-3/54201-84-2
Ka Lā Molecular: C30H37NO4
Molecular Weight: 475.62
Hōʻuluʻulu Manaʻo: 3,20-bis-Ethylenedioxy-5α,17α-dihydroxy-11β-(4-N,N-dimethylaminopheynl)-19-norpregn-9-ene; 3,20-bis-Ethylenedioxy-19-norpregna-5(10)9(11)dien-17-ol
Puke: E kūʻai ma ka lumi wela mai ka māmā a me ka makona.
Nā Palapala Kūlana (COA & HPLC etc.): Loaʻa

Ulipristal Acetate Powder (26784-99-4) Dinoa:

Ua apono ʻia ka Ulipristal acetate no ka hoʻohana ʻana i nā lāʻau lapaʻau ma ʻAmelika Hui Pū ʻIa i ka makahiki 2010. Aia ma ka World Health Organization's List of Essential Medicines, ʻo nā lāʻau lapaʻau kūpono loa a palekana e pono ai i kahi ʻōnaehana olakino.I ʻAmelika Hui ʻia ia ka NHS ma kahi o 17 paona no kēlā papa o ka mana hānau o ka hānau ʻana ma ka 2015. ʻOi e hoʻomaikaʻi i ke komo ʻana, hāʻawi kekahi i nā mea hiki i ka wā hāpai ke hāʻawi i kahi papa inoa no ka hoʻohana inā pono.

ʻO ka pauku ulipristal acetate pauka no ka modulators receptor progesterone, antagonistic a me nā hopena agonistic ma ka progesterone receptor. ʻO ia a me ke kino o progesterone receptor e hoʻopili ana e pale i ka progesterone a me nā progesterone receptors. Ka huehue o ke ʻano o kona hoʻokō pono ʻana ma ka manawa i lawe ʻia ai mākou i loko o ka hānō. Hoʻouna i ka hāʻawi ʻana i ka hyperplasia waena folika e hōʻoki i ka folliculogenesis a hōʻemi i ka ʻike ʻana o ka estradiol. Ka hoʻokele ʻana o ka luteinizing hormone ulu i loko o ka follicles o ke kūleʻa i hoʻopau ʻia ma 5 ~ 9 lā. ʻO ka Corpus luteum o ka hoʻokele mua ʻana i ka hiki ʻole o ka lohi o ka wā endometrial, akā hiki ke hana i ka hoʻēmi ʻana o ka endometrial me ka hoʻōla i ka 0.6 ± 2.2mm (ʻokoʻa ± SD).

Reference:

  • Puka aliʻi Pelekania: BNF 69 (69 ed.). Ahahui Pelekane o Pelekane. 2015. pp. 510, 560. ISBN 9780857111562.
  • Trussell, James; Raymond, Elizabeth G .; Cleland, Kelly (2014). "Hiki i ke ʻona kūwaho: kahi manawa hope e pale ai i ka ʻōpū ʻana i ʻike ʻole ʻia" (PDF). Nā Heluhelu Kūhelu Hou ma ke kānāwai a me ka hoʻoponopono kaulike. 6 (2): 7–38. ʻIvedlelo ʻia (PDF) mai ka mea mua ma 23 Kepakemapa 2010.
  • HRA Pharma (Malaki 2013). "Nā ʻāina kahi i hoʻokele ʻia ai ʻo ellaOne". Palisa: HRA Pharma. Ho‘ouna ‘ia mai ka mea mua ma 28 Iulai 2013. Ho‘omaka ia 25 Malaki 2014.

NA HALO A E HOOLAHA:

E kūʻai ʻia ana kēia ʻano mea no ka noiʻi noiʻi wale nō. Wahi a ke kūʻai aku. ʻAʻole no ka loiloi kanaka, ʻaʻole lāʻau lapaʻau, manu hoʻāno, a i ʻole e kōkua ʻia nā mea hale.


COA

HNMR

Nāʻike & nā hua'ōlelo huahana